Intraoperative Staging and Surgical Management of Stage IIIA/N2 Non-Small Cell Lung Cancer

Igor Brichkov, Steven M. Keller

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

Thorough staging of the mediastinum is an integral component of the operative treatment of non-small-cell lung cancer. Systematic sampling and systematic lymph node dissection provide similar and accurate staging information; however, systematic lymph node dissection is more likely to identify multiple levels of N2 disease and may be associated with improved survival. Although every effort should be made to identify N2 disease before surgery, if intraoperative metastases to mediastinal lymph nodes are discovered, the planned operation should proceed. Cisplatin-based adjuvant chemotherapy has moderate but proven survival benefit after resection of N2 disease. The role of postoperative radiotherapy remains uncertain.

Original languageEnglish (US)
Pages (from-to)381-391
Number of pages11
JournalThoracic Surgery Clinics
Volume18
Issue number4
DOIs
StatePublished - Nov 1 2008

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Intraoperative Staging and Surgical Management of Stage IIIA/N2 Non-Small Cell Lung Cancer'. Together they form a unique fingerprint.

Cite this